UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006838
Receipt No. R000007281
Scientific Title Multicenter pahse II tiral of combination therapy using abraxane and trastuzumab +-pertuzumab for HER2-positive locally advanced or metastatic breast cancer
Date of disclosure of the study information 2011/12/06
Last modified on 2020/03/15 13:37:22

No. Disposal Last modified on Item of update
1 Insert 2011/12/05 15:01:19
2 Update 2013/12/05 09:32:01 Interventions/Control_1
Interventions/Control_1
Key exclusion criteria
Key exclusion criteria
3 Update 2013/12/05 09:36:36 Email
TEL
Email
Organization
Organization
4 Update 2014/06/05 13:26:11 Public title
Public title
Acronym
Acronym
5 Update 2014/06/05 13:27:24 Narrative objectives1
Narrative objectives1
6 Update 2014/06/05 13:31:27 Interventions/Control_1
Interventions/Control_1
7 Update 2016/06/09 17:01:58 Name of primary sponsor
Organization
8 Update 2020/03/15 13:06:51 Recruitment status
Date of IRB
Last follow-up date
9 Update 2020/03/15 13:08:58 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
10 Update 2020/03/15 13:37:22 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures


Contact us.